Zurich Cantonal Bank’s Praxis Precision Medicines PRAX Stock Holding History

Zurich Cantonal Bank’s Portfolio PRAX Stock Details PRAX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.11M	Buy	9,280 +5,231	+129%	+$1.66M	0.01%	904
2026 Q1	$1.3M	Buy	4,049 +3,951	+4,032%	+$1.22M	﹤0.01%	1279
2025 Q4	$28.9K	Hold	98	–	–	﹤0.01%	2457
2025 Q3	$5.19K	Sell	98 -69	-41%	-$3.35K	﹤0.01%	2515
2025 Q2	$7.02K	Hold	167	–	–	﹤0.01%	2527
2025 Q1	$6.32K	Buy	+167	New	+$10.4K	﹤0.01%	2608
2022 Q4	–	Sell	-105	Closed	-$4K	–	2889
2022 Q3	$4K	Hold	105	–	–	﹤0.01%	2891
2022 Q2	$4K	Hold	105	–	–	﹤0.01%	2878
2022 Q1	$16K	Buy	+105	New	+$21.6K	﹤0.01%	2689

Other funds holding PRAX

Jupiter Topco New York $245B AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

OAG

Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Zurich Cantonal Bank's PRAX Position: Q2 2026 in Review

Zurich Cantonal Bank increased its Praxis Precision Medicines (PRAX) stake by 129% in Q2 2026, buying an estimated $1.66M and bringing the position to 9,280 shares worth $3.11M. The position accounts for 0.01% of the portfolio, ranked #904.

Zurich Cantonal Bank first reported a position in PRAX in Q1 2022 and has held it in 9 quarters since. 309 funds tracked by Wall St. Rank hold PRAX as of Q2 2026.

Zurich Cantonal Bank held 9,280 shares of Praxis Precision Medicines worth $3.11M as of Q2 2026.
Zurich Cantonal Bank bought 5,231 Praxis Precision Medicines shares in Q2 2026, an estimated $1.66M.
Praxis Precision Medicines made up 0.01% of Zurich Cantonal Bank's portfolio in Q2 2026, its #904 holding.
Zurich Cantonal Bank first reported a position in Praxis Precision Medicines in Q1 2022 and has held it in 9 quarters since.
309 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q2 2026.

Based on Zurich Cantonal Bank's 13F filing for Q2 2026, filed 12 Aug 2026.